In the perspectives article, published in the Nature Reviews Clinical Oncology, a group of researchers led by Dr François-Clément Bidard of the Department of Medical Oncology, Institut Curie and Université Paris Descartes, France discuss some of the potential avenues of research including the use of adequate statistical methods and well-annotated cohorts in biomarker discovery; an objective assessment of the level of evidence provided by each biomarker; the development of robust molecular or cellular surrogates of metastasis in patients; and original designs for clinical trials. Read more here.
Study mentioned: Bidard FC, et al. Translating metastasis-related biomarkers to the clinic-progress and pitfalls. Nat Rev Clin Oncol. 2013 Feb 5. [Epub ahead of print] PMID: 23381003
No comments:
Post a Comment